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mRNP remodelingNonsense-mediatedmRNA decay (NMD) is the best-characterizedmRNA surveillance mechanism that degrades
a premature-termination codon (PTC)-containingmRNA. DuringmammalianNMD, SMG1 andUPF1, key proteins
in NMD, join at a PTC and form an SMG1–UPF1–eRF1–eRF3 (SURF) complex by binding UPF1 to eRF3 after
PTC-recognition by the translating ribosome. Subsequently, UPF1 is phosphorylated after UPF1–SMG1 moves
onto the downstream exon junction complex (EJC). However, the cellular events that induce UPF1 and SMG1
complex formation and increase NMD efﬁciency before PTC recognition remain unclear. Here, we show that
telomere-maintenance 2 (TEL2) phosphorylation by casein-kinase 2 (CK2) increases SMG1 stability, which in-
creases UPF1 phosphorylation and, ultimately, augments NMD. Inhibition of CK2 activity or downregulation of
TEL2 impairs NMD. Intriguingly, loss of TEL2 phosphorylation reduces UPF1-bound PTC-containing mRNA and
the formation of the SMG1–UPF1 complex. Thus, our results identify a new function of CK2-mediated TEL2 phos-
phorylation in a mammalian NMD.
© 2013 The Authors. Published by Elsevier B.V. All rights reserved.1. Introduction
Nonsense-mediatedmRNAdecay (NMD) is a translation-dependent
mRNA surveillance mechanism that eliminates not only eukaryotic
mRNA harboring premature termination codons (PTC) that occur by
frameshift, alternative splicing, and point mutations, but also mRNA
that has a long 3′UTR, upstream ORF, or intron in the 3′UTR. This illus-
trates that NMD targets PTC-containing mRNA as well as natural
mRNA (Refs. [1–5] and references therein). Bioinformatics studies
have elucidated that around one-third of alternatively spliced mRNAs
are subjected to NMD [6] and around one-third of disease-associated
mutations are due to PTC-containingmRNAs [7]. Because NMD controls
translation for a variety of genes, NMDmalfunction or escape can cause
several human diseases by production of C-terminally truncated pro-
teins (Ref. [8] and references therein).
Mammalian NMD activity is enhanced by the presence of an
exon-junction complex (EJC) downstream of a PTC. EJC-dependent
NMD normally requires: (1) cap-bound heterodimeric protein (CBP)
20-CBP80, (2) at least one EJC downstream of a PTC, and (3) a PTC
more than ~55–50 nucleotides upstream of an exon-exon junction.terms of the Creative Commons
, which permits non-commercial
d the original author and source
dical Science and Engineering,
Korea. Tel.: +82 2 2220 2427;
.
blished by Elsevier B.V. All rights reWhen a translating ribosome stops at a PTC, up-frameshift factor
(UPF) 1 and suppressor with morphological effect on genitalia (SMG)
1 join heterodimeric eukaryotic translation release factor (eRF) 1 and
eRF3 to form the SMG1–eRF1–eRF3–UPF1 complex (SURF), by the
help of CBP80–UPF1 interaction [1,9], presumably while UPF1 inhibits
PABPC1–eRF3 interaction [10]. After SURF formation, the UPF1–SMG1
complexmoves to the downstream EJC, resulting in UPF1 phosphoryla-
tion by SMG1 [9]. SMG1 belongs to the phosphatidylinositol 3-kinase
(PI3K)-related protein kinases (PIKK) family and phosphorylates serine
and threonine [11]. SMG1-mediated UPF1 phosphorylation occurs at
twodistinguished sites. One isN-terminal threonine 28 that is supposed
to be bound by endonuclease SMG6,which replaces theUPF3–EJC inter-
action leading to cleavage of NMD targets [5,12,13]. The other site is at
four C-terminal serines (1073, 1078, 1096 and 1116), which are
supposed to be bound by the SMG5/7 complex, leading toUPF1 dephos-
phorylation [9,13].
Amammalian telomere-maintenance 2 (TEL2) (also known as TELO2
or hCLK2), themammalian ortholog of the yeast TEL2 gene, has pleiotro-
pic phenotypes including the response to replication stress [14–17].
Recent studies have revealed that casein kinase 2 (CK2) phosphorylates
TEL2,whichplays a role in the stability of the PIKK family proteins includ-
ing SMG1, themammalian target of rapamycin (mTOR), ataxia telangiec-
tasiamutated (ATM) and ATM- and Rad3-related genes (ATR) [18,19]. In
a mammalian cell, phosphorylated TEL2 forms a complex with SMG10,
RuvB-like (RUVBL) 1 and RUVBL2 (also known as Pontin and Reptin,
respectively), and SMG1, all of which are required for mammalian
NMD [18,20,21], suggesting that the phosphorylated TEL2 complex
may be involved in NMD. In addition, mutation of two constitutiveserved.
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TEL2 and instability of SMG1 in both human cells and mouse models
[18], suggesting that there may be a molecular mechanism by which
TEL2 phosphorylation induces NMD via increase in SMG1 stability.
In this study, we provide several lines of evidence demonstrating
that TEL2 phosphorylation by CK2 upregulates SMG1 stability and
increases UPF1 phosphorylation, which ultimately augments NMD.
Inhibition of CK2 activity or downregulation of endogenous CK2 or
TEL2 impairs exogenous as well as endogenous NMD targets. We also
show that in a mammalian cell, phosphorylation of TEL2 upregulates
complex formation with SMG1–UPF1 and increases joining of UPF1 to
PTC-containing mRNA. All of these results suggest that CK2-mediated
TEL2 phosphorylation coordinates NMD activity andmay serve to direct
mRNP remodeling during NMD.
2. Materials and methods
2.1. Cell culture, plasmid and siRNA transfection, cell lysis and
drug treatments
HeLa cells were grown in Dulbecco's modiﬁed Eagle's medium
supplemented with 10% fetal bovine serum and 1% penicillin/
streptomycin at 37 °C with 5% CO2. Transient transfections of DNA
plasmid and siRNA were done using Lipofectamine 2000 (Invitrogen)
and Oligofectamine (Invitrogen), respectively. Two days after siRNA
transfection, cells were re-transfected with a pmCMV-Gl (β-globin)
test plasmid [22], either nonsense-free (Norm) or PTC-harboring
(Ter), a pmCMV-GPx1 (glutathione peroxidase 1) test plasmid [23],
and a phCMV-MUP (mouse major urinary protein) reference plasmid
[24]. When speciﬁed, pCI-Neo–FLAG–UPF1 [25] was also transfected.
Total-cell lysates were obtained by hypotonic solution containing
10 mM Tris–Cl pH 7.5, 10 mM NaCl, 10 mM EDTA, and 0.5% Triton
X-100 followed by a 10-min incubation on ice as done in the previous
report [26]. Where speciﬁed, cells were treated with 100 μg/ml cyclo-
heximide for 4 h, 10 μM Wortmannin for 4 h, or 75 μM 4,5,6,7-
tetrabromo-benzimidazole (TBB) for 12 h.
2.2. Plasmid constructions
To construct N-terminal FLAG tagged pFLAG–TEL2-WT and pFLAG–
TEL2-2A, pFLAG (Sigma) was digested with NotI and XbaI and the
resulting vector fragment was ligated to a PCR-ampliﬁed product that
had also been digestedwith NotI and XbaI. The PCR product was gener-
ated using pDEST–FLAG–TEL2-WT or 2A [18] and two primers: 5′-CG
CGCGGCCGCGAGCCAGCACCCTCAGAGGTTCG-3′ (sense) and 5′-GCGTC
TAGATTACTAGGGAGACGCGGGGGTGAGG-3′ (antisense), where the
underlined nucleotides were recognized by NotI and XbaI, respectively.
2.3. siRNA
For downregulation of endogenous UPF1, SMG1 and CK2, siRNA
sequences were employed as previously described [9,27,28]. For control
siRNA and downregulation of endogenous TEL2, the following commer-
cial siRNAs were used: control siRNA (cat. no. SN-1003, Bioneer, Korea)
and TEL2 siRNA (cat. no. 1078794, Bioneer, Korea), respectively.
2.4. Immunoprecipitation (IP) and Western blotting (WB)
Cell lysates for the analysis of co-immunoprecipitated protein and
mRNA were generated before and after IP as previously reported [26].
In order to remove nonspeciﬁc protein–protein interaction, 150 mM
NaCl of cell lysate was used in IP using anti-UPF1, anti-FLAG or anti-
MYC antibody. Proteins were electrophoresed in 6–10% polyacryl-
amide and transferred to a PVDF membrane (Millipore). The following
antibodies were used: FLAG (Sigma), UPF1 (Cell signaling), SMG1 (Cell
signaling), MYC (Calbiochem), phosphorylated UPF1 (P-UPF1) [29],TEL2 [20], phosphorylated TEL2 (P-TEL2) [18], CK2α (Santa Cruz Bio-
technology) and β-actin (Santa Cruz Biotechnology). Antibodies were
diluted 1:200–1:5000 in 5% non-fat dry milk, 0.1% Tween 20/TBS and
incubated overnight at 4 °C with rocking. The protein–antibody com-
plexes were visualized using an ECL reagent (Thermo).
2.5. Semiquantitative and real-time quantitative RT-PCR
Total RNA was extracted using Trizol (Invitrogen) according to
manufacturer's protocol. To eliminate possible exogenous or endoge-
nous DNA contamination, RNA was further treated with RQ DNaseI
(Promega) for 30 min at 37 °C followed by RNA extraction. The RNA
was reverse-transcribed using random hexamers (Invitrogen) and
reverse-transcribed cDNAwas ampliﬁed by semiquantitative or quanti-
tative RT-PCR.
For semiquantitative RT-PCR (RT-sqPCR), β-Gl, GPx1, MUP, TBL2,
GADD45B and GAPDH mRNAs were ampliﬁed as previously described
[26,30,31]. PCR results were analyzed in 1% agarose gel using ethidium
bromide staining.
Real-time quantitative RT-PCR (RT-qPCR)was used to quantitate the
level of Gl, GPx1, MUP, TBL2, GADD45B and GAPDHmRNA using CFX96
(Bio-Rad) and Fast SYBR Green Master Mix (Applied Biosystems). The
primers used to amplify Gl, GPx1 mRNA were previously described
[26]. The primers used to amplify MUP, TBL2, GADD45B and GAPDH
mRNAs were the same as the primer pairs used in RT-sqPCR.
3. Results
3.1. Inhibition of CK2 activity reduces NMD efﬁciency
CK2 phosphorylates two TEL2 serines, serine 487 and serine 491,
which increases SMG1 stability [18]. To corroborate the theory that
TEL2 phosphorylation by CK2 augments NMD through an increase
in SMG1 stability and UPF1 phosphorylation, HeLa cells were transiently
transfected with exogenous NMD test and reference plasmids
(pmCMV-Gl and pmCMV-GPx1 test plasmids – either pmCMV-Gl
Norm and pmCMV-GPx1 Norm, both of which does not contain a PTC,
or pmCMV-Gl Ter and pmCMV-GPx1 Ter, both of which contain a PTC
[22,23] – and the phCMV-MUP reference plasmid [24]) followed by
treatment with the speciﬁed inhibitors, including cycloheximide (CHX,
a protein synthesis inhibitor by arresting translating ribosomes),
Wortmannin (Wort, canonical SMG1 inhibitor, preventing UPF1 phos-
phorylation) – CHX and Wort are known for NMD inhibitors [32–34] –
or TBB (CK2 inhibitor [18]). Western blotting (WB) using an anti-
P-UPF1 antibody (which detects SMG1-mediated phosphoserine 1078
of UPF1) and anti-P-TEL2 antibody (which detects CK2-mediated
phosphoserines 487 and 491 of TEL2), demonstrated that inhibition of
CK2 activity by TBB signiﬁcantly reduced phosphorylated UPF1
(P-UPF1/UPF1) and phosphorylated TEL2 (P-TEL2/TEL2) by ~3-fold
each compared to DMSO treatment, while the expressions of UPF1,
TEL2 and CK2 were comparable among cell lysates treated by inhibitors
(Fig. 1A). Expectedly, TBB treatment slightly reduced the amount of
SMG1 to ~70% in DMSO treated cells, suggesting that a decrease in phos-
phorylated UPF1 may result from the decreased amount of endogenous
SMG1 by inhibition of CK2 (Fig. 1A). All of the WB results suggest that
inhibition of CK2 activity may be involved in NMD by reducing two
key NMD proteins, SMG1 and phosphorylated UPF1.
To assess the role of CK2 activity in NMD, RT-sqPCR was employed.
The results revealed that TBB treatments, like CHXandWort, upregulate
Gl and GPx1 Ter mRNA compared to DMSO treatment (Fig. 1B, upper).
Moreover, TBB treatment increased endogenous NMD targets, TBL2
and GADD45B (Fig. 1B, bottom) [30,35]. To determine the quantitative
level of exogenous and endogenous NMD reporters, RT-qPCR was
performed. The results demonstrate that TBB indeed inhibits NMD like
CHX and Wort did: the level of Gl Ter and GPx1 Ter mRNA was ~2%
and ~8% of normal in DMSO treated cell lysates, respectively, but
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Fig. 1. Inhibition of CK2 kinase activity impairs NMD. (A) HeLa cells were treated with the indicated inhibitors and cell lysates were subjected to Western blotting (WB) using the
speciﬁed antibody. The four leftmost lanes analyzed 3-fold dilutions of lysates and demonstrate that WB conditions are semiquantitative. The normalized level in the presence of
DMSO was set to 100%. Mean values with standard deviations (S.D.) were calculated from four independent experiments. (B) HeLa cells were transiently transfected with NMD test
and reference plasmids. Semiquantitative RT-PCR (RT-sqPCR) was performed to compare relative amounts of exogenous (Top, Gl and GPx1, where MUP was employed for trans-
fection efﬁciency and a loading control) and endogenous NMD substrates (TBL2 and GADD45B, where GAPDH was employed for a loading control). (C) As in (B). However, quan-
titative RT-PCR (RT-qPCR) was performed. The levels of TBL2 and GADD45B mRNA were normalized to GAPDHmRNA. The columns and error bars represent the mean and standard
deviation of at least three independently performed experiments. Numbers above the bars indicate the mean value from the experiments. Asterisks denote statistically signiﬁcant
differences; *: p b 0.05, **: p b 0.01 (paired Student's t test).
1049S. Ahn et al. / Biochimica et Biophysica Acta 1829 (2013) 1047–1055~18% and ~17% of normal in the TBB treated cells. This suggests that in-
hibition of CK2 stabilized Gl TermRNA 9-fold andGPx1 TermRNA 2-fold
(Fig. 1C). Similar to exogenous NMD targets, we found that TBB treat-
ment upregulated TBL2 and GADD45BmRNA expression approximately
3- and 6-fold, respectively, indicating that inhibition of CK2 activity also
regulates endogenous NMD targets (Fig. 1C). All together, our ﬁndings
suggest that CK2 activity enhances NMD efﬁciency by increasing phos-
phorylated TEL2 and phosphorylated UPF1.3.2. Downregulation of endogenous TEL2 and CK2 reduces NMD
efﬁciency
To rule out the possibility that the effect of TBB treatment could be
due to pleiotropic effects rather than speciﬁc CK2 activity inhibition,
we examined the effects of endogenous TEL2 and CK2 on NMD by
employing siRNA-mediated knockdown. We transiently transfected
HeLa cells with siRNA that downregulates the expression of SMG1
1050 S. Ahn et al. / Biochimica et Biophysica Acta 1829 (2013) 1047–1055and UPF1 (each of which are essential for mammalian NMD), TEL2 or
CK2, or a nonspeciﬁc control siRNA. This was followed by transfection
of exogenous NMD test and reference plasmids. The amount of pro-
tein detected by WB (normalized to the abundance of β-actin to con-
trol for variations in protein loading) demonstrated that speciﬁc
siRNAs downregulated SMG1, UPF1, TEL2 and CK2 to approximately
20%, 20%, 30% and 30%, respectively, of the abundance found in the
presence of control siRNA (Fig. 2A). Similar to reduced phosphorylat-
ed UPF1 by TBB treatment in Fig. 1A, downregulation of TEL2 and CK2
signiﬁcantly reduced phosphorylated UPF1 by approximately 4-foldA
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for SMG1 stability as previously reported [18] (Fig. 2A). These WB re-
sults suggest that NMD may be repressed by reduced amount of en-
dogenous TEL2 and CK2.
To determine the role of endogenous TEL2 and CK2 on NMD, NMD
target mRNAs were analyzed by RT-PCR. RT-sqPCR (Fig. 2B) and
RT-qPCR (Fig. 2C) demonstrated that downregulating TEL2 reduced
NMD of PTC-containing Gl and GPx1 mRNA by approximately 2-fold.
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1051S. Ahn et al. / Biochimica et Biophysica Acta 1829 (2013) 1047–1055downregulating TEL2 upregulated endogenous NMD targets, TBL2 and
GADD45B, by approximately 1.4- and 3-fold (Fig. 2C). We conclude
that NMD probably involves CK2 and TEL2, and TEL2 phosphorylation.
However, it is possible that downregulation of TEL2 indirectly inhibits
NMD. To address this, we compared the stability of PTC-free and
PTC-containing mRNAs when TEL2 was downregulated by siRNA and,
after cells were incubated for 2 days, cells were treated with RNA poly-
merase inhibitor, 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB).
When expressed as a ratio of TEL2 siRNA to control siRNA, PTC-
containing Gl and GPx1 mRNA stability approximately doubled in
TEL2-depleted cells (Supplemental Fig. 1A). More importantly, the half-
lives of TBL2 and GADD45B were signiﬁcantly increased upon down-
regulation of TEL2 siRNA, but not control siRNA (Supplemental Fig. 1B),
suggesting that TEL2 is a regulator of NMD.-Actin ( - -Actin)
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UPF1 was decreased by approximately 2-fold, presumably, resulting
from the decrease of SMG1 (Fig. 3A), which, however, was less than
the decrease of phosphorylated UPF1 by TEL2 siRNA (compare Fig. 3A
with 2A). To conﬁrm the decrease of phosphorylated UPF1 by over-
expression of FLAG–TEL2-2A, endogenous UPF1 immunoprecipitation
(IP) in HeLa cell variants transiently expressing TEL2 was performed
(Fig. 3A, right panel). The lysates of transfected cells were obtained
and immunoprecipitated using anti-UPF1 antibody or, to control for
nonspeciﬁc IP, rabbit IgG (rIgG). Lysates subjected to WB before or
after IP demonstrated that none of the UPF1 proteins or β-actin
(negative-control protein) were immunoprecipitated using rIgG and
UPF1 antibody, respectively, indicating that the IPs were speciﬁc
(Fig. 3A, right panel). The results of phosphorylated UPF1 using anti-
p(S/T)Q antibody showed that overexpression of unphosphorylated
TEL2 reduced serine/threonine phosphorylated UPF1 by approximately
2-fold. These observations suggest that phosphorylation of TEL2 by CK2
increases SMG1 and phosphorylated UPF1.
Next, the effect of phosphorylation of TEL2 on NMD was examined.
RT-qPCR revealed that the expression of unphosphorylated TEL2 re-
duced NMD by approximately 2-fold compared to the expression of
normal TEL2 (Fig. 3B). Consistent with exogenous NMD test plasmids,
unphosphorylated TEL2 upregulated TBL2 and GADD45B by approxi-
mately 1.3- and 1.7-fold, respectively. Unexpectedly, repression of NMD
in natural targets by the expression of unphosphorylated TEL2 was not
as efﬁcient as repression by TBB treatment and downregulation of TEL2.
One possible explanation is that endogenous phosphorylated TEL2 may
be sufﬁcient to enhance NMD or other TEL2 phosphorylation sites by
CK2 play a role in SMG1 stability. The collective data suggest that CK2-
mediated TEL2 phosphorylation augments NMD.
In a samewaywith downregulation of TEL2 by siRNA,mRNA stability
was tested by employing DRB. When expressed as a ratio of TEL2-2A
overexpression to TEL2-WT overexpression, PTC-containing Gl andpF
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(Supplemental Fig. 2A). Similarly, the half-lives of TBL2 and GADD45B
were increased upon overexpression of TEL2-2A, but not TEL2-WT
(Supplemental Fig. 2B). All together, our ﬁndings suggest that CK2-
mediated TEL2 phosphorylation is a bona ﬁde regulator of NMD.
3.4. Unphosphorylated TEL2 inhibits UPF1 binding to Gl Ter mRNA
Our data indicate NMD is regulated by TEL2 phosphorylation.
Since UPF1 preferentially associates with PTC-containing mRNA in a
translation-dependent manner [26,36], UPF1 was expected to inefﬁ-
ciently associate PTC-containing mRNA when unphosphorylated TEL2
was expressed. To determinehowmuchunphosphorylated TEL2expres-
sion inhibits UPF1 binding to PTC-containing mRNA, HeLa cells were
transiently transfected with NMD test and reference plasmids. These
transfections also included either pFLAG–TEL2-WT or pFLAG–TEL2-2A.
The lysates of transfected cells were obtained and immunoprecipitated
using anti-UPF1 antibody or, to control for nonspeciﬁc IP, rabbit IgG
(rIgG) (Fig. 4A). In addition, to exclude the possibility that the RNA IP
was not speciﬁc, RT-sqPCR was performed. No Gl mRNA was detected
on the rIgG IP, showing that the RNA IP was speciﬁc (Fig. 4B, left
panel). RT-qPCR revealed that the level of Gl TermRNA before IPwas ap-
proximately 5% and 14% of normal in the expression of FLAG–TEL2-WT
and FLAG–TEL2-2A, respectively (Fig. 4B, right panel). Consistent with
the previous reports [26], RT-qPCR demonstrated that UPF1-bound Gl
Ter mRNA after IP was 198% of normal, which means UPF1 binds
PTC-containing mRNA about 40 times more efﬁciently than does its
PTC-free counterpart (Fig. 4B, right panel, compare 5% with 198%).
Surprisingly, when unphosphorylated TEL2 was expressed, RT-qPCR
demonstrated that FLAG–TEL2-2A expression decreased the UPF1-
bound PTC-containing mRNA, Gl Ter mRNA, to about 15% of normal,
indicating that unphosphorylated TEL2 prevents the binding of UPF1 to
PTC containing mRNA (Fig. 4B, right panel). These observations areLAG-
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efﬁciency by blocking UPF1 from binding to PTC-containing mRNA.
3.5. Phosphorylated TEL2 regulates the formation of UPF1–SMG1
complex
Since UPF1 directly binds SMG1, preceding UPF1 phosphorylation
[9], we expected that phosphorylated TEL2 might upregulate the
complex with SMG1 and UPF1 by increasing SMG1 stability, which
is expected to join NMD targets. To address this hypothesis, HeLa
cells were transiently transfected with TEL2 or control siRNA. TEL2
siRNA reduced endogenous TEL2 to 20% of normal, and was subse-
quently transfected with pCI-Neo–FLAG–UPF1, where the expression
of FLAG–UPF1 proteins was nearly double the level of endogenous
UPF1 (Fig. 5A, left panel). Cell lysates were then subjected to before or
after IP using anti-FLAG antibody. Consistent with Fig. 2A, endogenous
SMG1 was reduced upon depletion of TEL2. As a result of reduced
endogenous SMG1, the levels of co-immunoprecipitated SMG1 with
FLAG–UPF1 decreased by approximately 2-fold (Fig. 5A, right panel).
Moreover, endogenous TEL2 was co-immunoprecipitated with FLAG–
UPF1, which was reduced by downregulation of TEL2 (Fig. 5A, right
panel).
To test whether phosphorylation of TEL2 is also involved in UPF1–
SMG1 complex remodeling, HeLa cell lysates that were transiently
transfected with pCMV–MYC–UPF1 and either pFLAG–TEL2-WT or
2A were employed for IP using anti-MYC antibody (Fig. 5B, right
panel), where the MYC–UPF1 and FLAG–TEL2 variant proteins were
expressed at similar level of endogenous UPF1 and TEL2, respectively
(Fig. 5B, left panel). The inhibition of UPF1–SMG1 complex formation
was also observed with a unphosphorylated TEL2-mediated decrease
in the coIP of MYC–UPF1 with SMG1, but not with UPF2, suggesting
that inhibition of NMD by overexpression of unphosphorylated TEL2
may result from the reduction of the SMG1–UPF1 complex (Fig. 5B,
right panel).
Next, the reciprocal experiments were performed. HeLa cell lysates
that were transiently transfected with pFLAG, pFLAG–TEL2-WT or
pFLAG–TEL2-2A were analyzed before or after IP using anti-FLAG
(Fig. 5C). Results have shown that SMG1 and UPF1 was more
co-immunoprecipitated with FLAG–TEL2-WT than FLAG–TEL2-2A,
suggesting that phosphorylated TEL2 upregulates, presumably, the
TEL2–SMG1–UPF1 complex (Fig. 5C). Furthermore, endogenous UPF2
was not observed in co-immunoprecipitates, suggesting that the
TEL2–SMG1–UPF1 complex is disassembled before the SMG1–UPF1
complex moves to the UPF2-bound EJC (Fig. 5C).
4. Discussion
Mammalian NMD involves many proteins: CBP80, CTIF, PNRC2,
UPF1, SMG1, eRF1, eRF3, UPF2, UPF3 or UPF3X, SMG8, SMG9,
RUVBL1, RUVBL2 etc. A broad spectrum of studies have reported on
the molecular mechanisms after PTC recognition by a ribosome; SURF
complex formation, UPF1 phosphorylation by SMG1, dephosphorylation
of phosphorylated UPF1, endonuclease activity of SMG6 that binds
phosphorylated UPF1, disassembly of UPF1-bound complex on the EJC
and exonuclease activity degrading NMD targets (see recent reviews
[1,3,37,38]). In contrast to various mechanistic studies about NMD
after PTC recognition, few lines of evidence about the events before
PTC recognition have shown that SMG1 directly interacts with SMG8
and SMG9, which suppress SMG1 kinase activity and are expected to
form the complex before SMG1 forms the SURF complex [39]. In addi-
tion, RUVBL1 and 2 stabilize SMG1 and augments NMD through induc-
tion of the mRNA surveillance complex before a ribosome recognizes
PTC [21]. Interestingly, the CK2 phosphosite of TEL2 is immuno-
precipitated with both RUVBL1 and 2 via direct binding to PIH1D1
[18], suggesting that RUVBL1 and 2 may be able to regulate NMD
through TEL2 phosphorylation. Furthermore, phosphorylated TEL2mostly localizes in the cytoplasm and nuclear periphery [18],
where a majority of NMD occurs, suggesting that phosphorylated
TEL2 may have NMD-related function in cytoplasm besides replica-
tion. Together, all these observations have driven us to determine
the function of TEL2 phosphorylation on NMD and to describe the
events surrounding SMG1–UPF1 binding to PTC-containing mRNA.
All of our observations in this study provide insights into the dynamics
of UPF1binding to PTC-containingmRNA, induced byCK2-mediated TEL2
phosphorylation, which stabilizes endogenous SMG1. This ﬁnding high-
lights the importance of TEL2 as a key regulator of SMG1–UPF1 joining
to a target of PTC-harboring mRNA. The following observations support
this notion: NMD is inhibited upon (1) the inhibition of CK2 activity
(Fig. 1), (2) downregulation of endogenous TEL2 and CK2 (Fig. 2), and
(3) overexpression of unphosphorylated TEL2 (Fig. 3). Furthermore, we
elucidate that UPF1 binds PTC-containing mRNA more efﬁciently than
its PTC-free counterpart in the presence of phosphorylated TEL2, while
expression of unphosphorylated TEL2 inhibits UPF1 binding to PTC-
containing mRNA (Fig. 4.). In addition, we elucidate that phosphorylated
TEL2 remodels theUPF1–SMG1 complex, presumably,which are involved
in NMD. In summary, before the SMG1 and UPF1 complex join NMD tar-
gets, SMG1 stability is upregulated by the formation of the phosphorylat-
ed TEL2 complex with PIHD1 and RUVBL1 and 2. Increased endogenous
SMG1 augments UPF1 phosphorylation, which ultimately increases
NMD efﬁciency.
Future studies are expected to unlock more about the upstream
events triggering TEL2 complex formation, which may answer why
NMD efﬁciencies are different among various cell lines and tissues.Acknowledgement
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